Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Neuroendocrine

Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.

230 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Neuroendocrine trial results

Completed

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

NCT02259725

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +25 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • USC Norris Oncology Hematology-Newport Beach Newport Beach, California, United States
View Trial Details
Completed

Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer

NCT00704730

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +16 more
Locations
  • University of Alabama at Birmingham, Comprehensive Cancer Center Birmingham, Alabama, United States
  • TGEN Clinical Research Service at Scottsdale Healthcare Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Burbank, California, United States
View all 113 locations
View Trial Details
Completed

A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma

NCT01652547

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
Locations
  • Novartis Investigative Site Essen, Germany
  • Novartis Investigative Site Lausanne, Switzerland
  • Novartis Investigative Site Zurich, Switzerland
View Trial Details
Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations
  • The Angeles Clinic and Research Center Los Angeles, California, United States
  • Hackensack Medical Center Hackensack, New Jersey, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Completed

Nintedanib(BIBF1120) in Thyroid Cancer

NCT01788982

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +17 more
Locations
  • A.Z. St. Jan Bruges, Belgium
  • Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universitair Ziekenhuis Antwerpen Edegem, Antwerpen, Belgium
View all 27 locations
View Trial Details

Related conditions